Health Affairs, 27, no. 1 (2008): w34-w40 (Published online 27 November 2007) doi: 10.1377/hlthaff.27.1.w34 © 2008 by Project HOPE	New Online   New Issue: China & India   Obesity In China   Pay Cuts For Medicare Docs   Access To Care Woes

This Article Full Text (HTML) Reprint (PDF) Submit a response to this article Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services E-mail this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to My Personal Archive Download to Citation Manager Reprints & Permissions Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Culliton, B. J. Search for Related Content PubMed PubMed Citation Articles by Culliton, B. J. Related Collections Consumer Issues Research And Technology

Web Exclusives

INTERVIEW

Promoting Medical Innovation While Developing Sound Social And Business Policy: A Conversation With Thomas G. Roberts

The development of "targeted biologics" as cancer therapy has made the field ripe for investment from the private sector and is changing the face of cancer medicine, while also raising important policy concerns about price, profit, and continued innovation. In this interview Barbara Culliton talks with Thomas Roberts, who sees this world from a unique perspective. Roberts, an oncologist, has practiced at the Massachusetts General Hospital and is currently thinking about innovation as a hedge fund manager.

                      What's this?